mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0087 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |